Paper II
2022 May (Supplementary) (2010 Scheme)

Question

Selective estrogen receptor modulators

Q160.3 marksShort Answers

Answer

Tamoxifen, Raloxifene — act as estrogen receptor agonists in some tissues and antagonists in others (tissue-selective); tamoxifen is antagonist in breast (used in ER-positive breast cancer) but agonist in endometrium and bone, while raloxifene is antagonist in breast and endometrium but agonist in bone (used for osteoporosis prevention without the endometrial cancer risk of tamoxifen).

Other Years Asked


Revise MBBS
Preview